Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

PAI-1 inhibitors TM-5275 and TM-5441 show promise to treat diabetic nephropathy

July 4, 2011

Vivus seeks approval in U.S. of avanafil for erectile dysfunction

July 1, 2011

Final data presented from phase I trial of X-Excite versus Viagra

June 27, 2011

FDA approves CorMedix's SPA for phase III CRMD-001 trial

June 23, 2011

Phase I results reported on renin inhibitor VTP-27999

June 20, 2011

Bardoxolone methyl enters pivotal trial in patients with chronic kidney disease and type 2 diabetes

June 17, 2011

Enrollment complete in phase II CRMD-001 trial in contrast-induced acute kidney injury

June 16, 2011

FDA grants orphan drug status to Neo-Urinary Conduit

June 15, 2011

NovaDel Pharma files IND with FDA for sildenafil oral spray

June 7, 2011

Ferring and Kyowa Hakko Kirin conclude copromotion agreement for desmopressin tablets in Japan

June 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...